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Abstract A growing knowledge regarding the influence of
exercise on adverse physiologic outcomes associated with
cancer and its treatment exists. Aside from its effects on
psychological behavior, quality of life, and cancer-related
fatigue, physical exercise can target physical and cardio-
respiratory fitness, insulin regulation and metabolic syn-
drome, body weight and composition, and immune function
in tumor patients. The increasing number of study results for
different cancer types, which prove the positive influences of
physical activity in cancer patients, changed the contradictory
opinions which existed until the end of the last century.
Although an increasing number of studies showing the posi-
tive effects of physical activity and more specifically of en-
durance and resistance training in cancer patients have been
published, the underlying mechanisms are mostly unknown.
Thus, we summarized the current knowledge of the effects of
physical activity and specific training in different tumor enti-
ties with specific respect to the possible underlying mecha-
nisms. Especially, the association between physical activity
and (1) the improvement of fatigue and the role of free radicals
in this process, (2) the counterbalance of tumor-induced ca-
chexia, (3) the improvement of the immune system for sup-
portive tumor treatment, and (4) the possible role of epigenetic
modulation against tumor and tumor treatment-dependent
adverse physiologic outcomes is focused.
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Positive effects of physical activity in tumor patients
The benefits of exercise on some of the adverse physiologic
outcomes associated with cancer and its treatment, including
physical and cardio-respiratory fitness, fatigue, insulin reg-
ulation and metabolic syndrome, body weight and compo-
sition, and immune function, were recently summarized in a
review by Ingram and Visovsky [36]. These effects add to
previously described and well-known effects of physical
activity on psychological behavior, quality of life, and
cancer-related fatigue in cancer patients [6, 41].
Until the 1990s, physical activities were often contraindi-
cated for cancer patients. However, the increasing number of
study results, which have proven the positive influence on the
holistic situation of cancer patients, brought about a change
[32, 73]. In Germany, the first experiences with therapeutic
exercise interventions in patients with neoplastic diseases date
back over 30 years. In the summer of 1980, Prof. Schüle
examined whether physical activity in patients with gyneco-
logical tumors is feasible—this was the first study nationwide.
Based on his experience, the first cancer sports group was set
up. This group pursued an improvement of mood, social
interaction, and well-being [75].
By now, latest studies show the positive influence of dif-
ferentiated endurance and resistance training programs in
various cancer entities, however, with different levels of evi-
dence. The national expert panels in North America, Aus-
tralia, and Germany agree that physical activity in patients
with oncological diseases is feasible, both during and after
medical treatment. Exercise programs can improve physical
fitness, muscular strength, and quality of life and have the
potential to reduce fatigue. To date, these effects can be
observed especially in patients with breast cancer, prostate
cancer, and hemato-oncological diseases [8, 9, 32, 73].
In 1989, for possibly the first time, the influence of physical
activity during chemotherapy was examined in 45 breast cancer
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patients. Patients that took part in the endurance training pro-
gram on the bicycle showed a significant better physical perfor-
mance compared to the control group [88]. Numerous studies
were able to prove the holistic effects of endurance training
during (high dose) chemotherapy [7, 42]. Recent studies with
breast cancer patients show that resistance training can also be
performed during chemotherapy without causing complications
[17, 77]. Patients can also exercise during radiotherapy and
hormone therapy [39]. They benefit from an increase in muscle
strength and lean body mass and a reduction of the fatigue
syndrome. Further, exercise programs have positive effects on
psychological and social parameters. A decrease in anxiety and
an increase in quality of life can be observed [1, 58, 73].
Physical exercise interventions in oncology pursue many
specific aims that differ from the rehabilitation of other
diseases. A targeted physical exercise program can, for
example, positively influence the side effects of a prostate
cancer treatment. A significant reduction of incontinence
following a controlled exercise intervention has been dem-
onstrated in several randomized studies [6, 59].
Whether resistance training, endurance training, or the
combination of both has more effects on, for example,
cancer-relevant biomarkers has rarely been investigated until
today. The individual preference of the patient has to be taken
into account when deciding on the method in order to improve
quality of life [17]. Resistance training shows better physical
effects in the field of muscle hypertrophy, while endurance
training suggests better results in the field of endurance ca-
pacity (VO2 max) [18]. Both types of training can help reduce
fatigue symptoms [77].
Additionally, large epidemiological studies like the
nurses’ health study show a positive correlation between
physical activity in breast cancer patients and the relapse
and mortality rate of up to 40 %. The risk of relapse can be
reduced through physical activity in colon cancer as well as
in breast and prostate cancer [33, 40, 55].
Improvement of fatigue by physical activity and the role
of free radicals
A major problem that 25–99 % of all cancer patients experi-
ence during and/or after medical treatment is cancer-related
fatigue (CRF). CRF has been identified as a multidimensional
construct that involves a persistent physical, emotional, and/or
cognitive tiredness or exhaustion that is not related to exertion
level and is not relieved by rest or sleep. Therefore, a reduction
of daily activities and motivation as well as a negative impact
on quality of life and functional capacity can be observed [5,
12]. Mechanisms proposed as underlying cancer-related fa-
tigue include 5-HT neurotransmitter dysregulation, vagal af-
ferent activation, alterations in muscle and ATP metabolism,
hypothalamic–pituitary–adrenal axis dysfunction, circadian
rhythm disruption, and cytokine dysregulation. However, to
date, the entire etiology of CRF is poorly understood, and the
relative contributions of the neoplastic disease, various forms
of cancer treatment, and comorbid conditions are widely
unknown [67]. Especially, the involvement of oxidative stress
as a general mechanism described to induce the fatigue syn-
drome is rarely evaluated in cancer patients, as well as its
correlation to fatigue. Oxidative stress is described as an im-
balance between reactive oxygen species (ROS) and the ability
of antioxidant systems, both enzymatic and nonenzymatic, to
neutralize them. Aside from a normal ROS production during
aerobic metabolism, increased free radical levels potentially
damage, for instance, cell membranes, proteins, and DNA
and can be observed in pathophysiological conditions [78].
Further certain chemotherapeutic drugs (e.g., anthracycline)
unfold their therapeutic effect by generating free radicals [20].
A principal involvement of oxidative and nitrosative stress in
the development of chronic fatigue was recently described by
Maes and Twisk [47] on the basis of a bio(psychosocial) model
which describes the pathophysiology of chronic fatigue.
Patients that experience chronic fatigue syndrome possess
higher peroxide concentrations in their blood plasma [46].
When considering the points of clinical overlap (especially
fatigue, immunological abnormalities) between patients with
CRF and patients with chronic fatigue syndrome, similar obser-
vations can be expected in CRF patients [54]. In the long term,
an increased oxidative stress level in the skeletal muscle is held
to be responsible for a reduction in muscle mass and could
therefore be associated with the physical and peripheral com-
ponents of CRF [30]. On the other hand, an acute exercise-
induced increase of intracellular ROS can contribute to an
improved muscle contraction due to an increased calcium
release in the muscle and an improved ATP production [66,
69, 85]. Clearly, oxidative stress is necessary to a certain extent.
In this context, the importance of the antioxidant defense
systems needs to be considered.
The influence of physical activity on CRF has been well
demonstrated in the meta-analyses by Cramp and Daniel
[19] and Speck et al. [80]. Both were able to show that
physical exercise is an effective intervention to counteract
CRF. However, the influence of physical activity seems to
depend on the cancer type, disease stage, and the time point
of intervention. Even though a special, evidence-based
physical activity program for CRF patients does not yet
exist, both aerobic and resistance exercises show positive
effects. Recent studies suggest that exercise interventions
that are conducted in the aftercare show greater benefits than
those administered during the medical treatment phase [53].
The influence of physical activity on oxidative stress, as a
possible mediator of CRF, has hardly been studied in cancer
patients. While intensive physical exercise is associated
with an increased oxidative stress level, moderate physical
exercise can decrease oxidative stress by improving the
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antioxidative capacity [3, 65]. Knop et al. [43] investigated
whether a long hiking trip (over 500 km) can influence
oxidative stress and antioxidative capacity in breast cancer
and prostate cancer patients. In the group of women who
participated in a moderate 7-week hike, there was no signif-
icant change in ROS throughout the hike however a signif-
icant increase in antioxidative capacity. In the prostate
cancer patients participating in the 5-week high-altitude
hike, ROS concentration increased and the antioxidative
capacity decreased initially. However, after a phase of re-
generation, the ROS concentration decreased and the anti-
oxidative capacity improved significantly. The study group
therefore concludes that the antioxidative capacity of cancer
patients can be positively influenced by long hiking trips
[43]. An exercise-induced increase in endogenic, enzymatic
antioxidants has proven to attenuate the side effects of
certain cancer treatments [32, 79]. Regarding CRF, a re-
duced oxidative stress level may play an important role in
protecting skeletal muscle and therefore reducing CRF [79].
Yet, further studies are necessary to fully understand the
etiology of CRF and the role of free radicals and physical
exercise in this context. Presumably, physical activity does
not only influence the physiologic and biologic components
of CRF, but also has a psychological, social, and behavioral
impact that indirectly influences fatigue outcomes.
Counterbalance of tumor-induced cachexia
through physical exercise
Up to half of all cancer patients are affected by cancer
cachexia, a syndrome defined by weight loss, asthenia, and
anorexia [81]. The literature suggests that approximately
20 % of all cancer deaths are related to cachexia rather than
a direct tumor-related cause [84]. In general, cachexia is
defined as the loss of muscle, with or without fat, and is
frequently associated with anorexia, inflammation, and in-
sulin resistance [2]. Since the major problem is the reduction
of muscle mass, strategies are necessary to counterbalance the
loss [83]. Until today, no specific interventions have proven to
be effective in preventing or reversing the problem of cachex-
ia. Besides pharmacological and nutritional therapies, exercise
programs could help attenuate skeletal muscle wasting [62].
Only few studies have investigated the influence of phys-
ical activity on cachexia in cancer patients. Yet, these studies
were able to show that resistance training leads to an increase
in muscle strength and muscle mass. However, most of these
studies involved breast and prostate cancer patients, who
generally have a relatively low incidence of cachexia [17,
29, 73, 76]. The underlying mechanisms on the molecular
level remain unclear.
Cachexia is strongly associated with chronically elevated
serum levels of (pro)inflammatory cytokines, such as tumor
necrosis factor α (TNF-α), interleukin-6 (IL-6), and interferon-
γ (IFN-γ) [25]. Animal studies could show that an injection of
TNF-α leads to a loss of muscle and fat mass by activating the
proteasomal degradation of proteins via the NFκ pathway [67].
Further cachexia-reducing effects have been described for the
injection of IFN-γ and IL-6 antibodies [48, 90]. Interestingly,
physical activity has the potential to reduce the proinflamma-
tory environment. Petersen and Pedersen [60, 63] were able to
demonstrate that exercise causes a strong short-term increase in
IL-6, which ends up in a reduction of TNF-α and an increase in
anti-inflammatory cytokines. It could be shown that endurance
training as well as the substitution of erythropoietin down-
regulates chronic serum levels of IL-6 [14]. The authors assume
that endurance training may prevent the development of ca-
chexia however, on the contrary, may have negative effects on
an existing cachexia. Beside the mentioned cytokines, the
insulin-like growth factor 1 (IGF-1) seems to affect cancer
cachexia in a positive manner [72, 74]. Schmidt et al. observed
a lower reduction in muscle and body mass in those animals
receiving IGF-1 injections [71]. Berg and Bang described
exercise-induced IGF-1 elevations [11].
Another potential link between physical activity and a
reduction in cachexia has been reported by Sandri et al.,
who described an exercise-induced increase of the transcrip-
tional cofactor PGC-1α [68]. PGC-1α inhibits the transcrip-
tion factor FoxO, which promotes the expression of proteins
making protein degradation. Additionally, it could be demon-
strated that resistance training as well as endurance training
inhibits muscle wasting by phosphorylating protein kinase B
(Akt) and the transcription factor FoxO [87]. An elevated activ-
ity of the kinase mTOR, which is a key player in the production
of muscle proteins, could only be observed in the resistance
training group. The same animals showed an increase in the
activity of satellite cells which was associated with elevated
levels of the transcription factor MyoD. A resistance training-
induced activation of mTOR has also been reported [4, 28].
Further, patients may benefit from combined interventions.
Penna et al. examined the influence of an omega-3 fatty acid
substitution alone and in combination with an endurance exer-
cise program in tumor-bearing mice [61]. Animals in the com-
bined intervention group had a significant lower loss of muscle
mass and strength. In order to define optimal exercise inter-
ventions for cachexia patients, it is important to analyze and
understand the underlying mechanisms on the cellular level.
Therefore, further randomized trials with homogeneous human
samples and well-defined exercise programs are necessary.
Effects of physical activity on the immune system-relevant
aspects for supportive tumor treatment
Today, it is not only suggested but also generally accepted
that the immune system plays a role in reducing cancer risk
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by recognizing and eliminating abnormal cells or by means
of acquired and/or innate components of the immune system
[37]. The role of the immune system in endogenous cancer
defense has also already been demonstrated. It is well
known that the immune system initiates tumoricidal activi-
ties. Therefore, therapeutic strategies will be developed and
used which are based on the therapeutic potential of the
endogenous immune system [22]. Immune therapies play
an increasing role in cancer treatment and are a novel
approach in the treatment of systemic malignancies. Passive
and adaptive immunotherapy has been applied in a wide
variety of solid tumors such as malignant melanoma, renal
cell carcinoma, and ovarian cancer [56]. When regarding the
regulatory role of exercise for the immune system, moderate
exercise seems to have a protective effect, whereas repeated
bouts of strenuous exercise can result in immune dysfunc-
tion. Therefore, a potential role of exercise in endogenous
tumor prevention and defense is suggested [27, 52]. Fur-
thermore, immune function can be impaired by cancer treat-
ment leading to an increased risk of inflammatory diseases.
Recently, we were able to show the influence of physical
activity on fever and pneumonia risk in leukemia and lym-
phoma patients during therapy-induced aplasia. We ob-
served significant differences between the intervention and
the control group in both the leukemia and the lymphoma
patients [10]. These study results are in accordance with
recent studies investigating immunological and hematolog-
ical changes following high-dose chemotherapy. Three dif-
ferent studies show an improved or at least unchanged
immune cell recovery in patients who had received high-
dose chemotherapy and exercised for 2 to 12 weeks. Espe-
cially, negative impacts on immune function could not be
observed [23, 24, 31]. Also, in breast cancer survivors,
exercise induces greater lymphocyte activation after a 6-
month exercise intervention [34]. Therefore, the question
arises whether and to what extent physical activity or spe-
cific exercise interventions can influence the immune sys-
tem in terms of preventing cancer, enhancing immune
therapy, and avoiding treatment-related immune dysfunction
and therefore inflammatory diseases.
In cancer prevention, the regulatory role of physical
activity or rather specific exercise on pro- and anti-
inflammatory cytokines may be of major importance. In-
creased levels of proinflammatory factors, such as C-
reactive protein (CRP), IL-6, or TNF-α, and decreased
levels of anti-inflammatory factors, such as adiponectin,
have been associated with an increased cancer risk. An
association between chronic physical activity and lower
levels of the inflammatory markers CRP, serum amyloid
A, IL-6, and TNF-α in both men and women has been
shown in some but not all exercise intervention studies
[52]. Furthermore, an exercise-induced release of mainly
anti-inflammatory cytokines by the skeletal muscle and an
exercise-induced long-term alteration of cytokine release
and receptor response are suggested [63]. In the wide range
of cytokines influenced by exercise, the macrophage migra-
tion inhibitory factor (MIF) could be relevant for cancer
defense. MIF regulates both the invasion of immune cells
and the cancer cell migration in a contrary direction. While
the immune cell invasion is inhibited and the natural killer
(NK) cell activity is decreased by MIF, the tumor cell
invasion is enhanced by MIF [44]. Recently, we were able
to show that MIF is downregulated by a single bout of
intensive exercise [70]. Further studies must show whether
an exercise-induced alteration of cytokines, such as MIF,
can influence the invasion of immune cells and tumor cells
in a different direction and therefore contribute to defending
against cancer.
On the cellular level, exercise-induced improvements in
immune cell function can be found. The clinical significance
of antiviral and anticancer defenses in NK cells, a heteroge-
neous population of lymphocytes, has been demonstrated
[13, 21]. In postmenopausal breast cancer survivors, physi-
cal exercise increased NK cell cytotoxicity and unstimulated
[3H]thymidine uptake by peripheral blood lymphocytes,
indicating an improved cellular immune defense by exercise
[27]. When considering the suggested biological and thera-
peutic relevance of tumor defense, NK cells are an important
first line of defense against tumor growth. Further, the
important immunoregulatory properties of their CD56dim
and CD56bright subsets mark them as candidates for immu-
notherapy for cancer. The redistribution of CD56dim and
CD56bright cells in response to exercise may be a therapeu-
tic benefit in children recovering from cancer; however,
these speculations still remain undetermined. It has also
been suggested that the stimulation of the CD56bright sub-
set with the NK cell compartment may be a therapeutic
effect to prevent relapse of a residual disease; exercise might
be an excellent strategy to achieve this effect [82]. Distribu-
tion of immune cells seems to be of major importance for
immune defense also against cancer. Exercise stress induces
a substantial redistribution of T cells within lymphoid and
nonlymphoid organs. It can be hypothesized that these
stress-induced effects on lymphocyte trafficking might en-
hance immune surveillance and vigilance [45] and thus
immune defense against cancer. Mechanisms leading to an
altered immune cell migration across the vascular barrier
could be involved. In lung cancer patients, 4–6 weeks of
presurgical exercise training induced a systemic decrease of
the intracellular adhesion molecule (ICAM)-1 in the blood.
ICAM-1 is a cell surface glycoprotein that is upregulated in
response to a variety of inflammatory mediators and is
essential for controlling the migration of immune cells,
cancer cell invasion, and metastasis. It plays a major role
in lung tumorigenesis, and high systemic concentrations
may serve as a useful indicator of advanced disease and
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are associated with poorer prognosis in lung cancer patients
[38]. It can be speculated that an exercise-mediated change
of cytokine profiles, surface molecule expressions, and sub-
sequent alteration of immune cell distributions and also
cancer cell invasions are of importance for tumor prevention
and defense.
Can epigenetic modulation due to physical activity
be involved in resisting cancer?
Epigenetic modulations are defined as covalent alterations of
the chromatin which do not affect the DNA sequence. The
most prominent epigenetic alterations are changes in DNA
methylation and posttranslational modifications, like acetyla-
tion, methylation, phosphorylation, and sumoylation of his-
tone proteins [26, 35]. However, there is still a great lack of
knowledge regarding the functions and interactions of epige-
netic modulations. The mentioned epigenetic alterations can
act as short- and long-term regulators of gene expression.
Most tumor cells show abnormal epigenetic patterns. Until
today, it remains unclear whether the dysregulation of epige-
netic control is the effector or the result of neoplastic diseases
[86]. Hypermethylation in promoter regions of tumor suppres-
sor genes, for example, leads to gene silencing and a general
DNA hypomethylation, which is associated with gene insta-
bility [89]. New promising pharmaceutical strategies, like
histone deacetylase (HDAC) inhibitors, try to manipulate
proteins which are involved in epigenetic modifications.
Interestingly, physical activity and nutrition can affect the
epigenome in a similar manner. The duration of these effects
vary from reversible short-term effects to long-lasting and
generation-spanning effects. Nakajima et al. [57] described
lower, age-dependent reductions of ASC gene methylation,
which encodes for proinflammatory cytokines, in exercising
individuals. Further, Zeng et al. [91] were able to show that
exercise leads to the hypomethylation of a breast cancer-
specific tumor supressor gene.
Besides the influence on DNA methylation patterns, phys-
ical activity has an immediate impact on HDACs and histone
acetyltransferases [49, 50]. Until today, only few studies have
investigated the influence of physical activity on these
enzymes. McKinsey et al. [51] were able to show that HDAC
class II enzymes are enriched in striated muscle cells. Knock-
out experiments of different class II HDACs lead to endothe-
lial dysfunction and cardiac hypertrophy [15, 16]. HDACs can
be inactivated through phosphorylation, altered intracellular
oxidative stress levels, and energy balances [51]. Physical
activity does strongly affect all of these three factors.
Finally, Potthoff et al. [64] found elevated ubiquitin-
dependent degradation levels of class II HDACs after an
exercise intervention in mice. McGee and Hargreaves [50]
were not able to verify these results in humans however
found elevated levels of HDAC 5 ubiquitination immediate-
ly after a single bout of exercise.
In order to improve the knowledge of the impact of phys-
ical activity on epigenetic patterns, further studies are neces-
sary. Aside from myocytes, these studies should also regard
other tissues, for example, endothelial cells, progenitors, and
circulating cells of the immune system. To obtain more de-
tailed information on the impact of exercise on specific genes,
it would be helpful to use techniques like ChIP assays and
immunoprecipitation. The observed effects may help support
pharmaceutical cancer treatments. Additionally, the properties
of physical activity on the epigenetic level could be used to
optimize preventive and rehabilitative exercise programs.
Conclusion
The growing evidence, regarding the beneficial effects of
physical activity and moreover specific endurance and resis-
tance training interventions for cancer patients during and
after cancer treatment, lead to an implication of physical
training as a supportive cancer treatment. Further knowledge
about the involved mechanisms and the “dose response”must
be given in order to exhaust the full potential of physical
exercise in cancer patients.
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